Skip Navigation
request an appointment my chart notification lp musc-logo-white-01 facebook twitter youtube blog find a provider circle arrow
MUSC mobile menu
Institute of Psychiatry

%CDT and %dCDT Articles

Clinical Chemistry

Arndt T., van der Meijden B.B., Wielders J.P.M., (2008) Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clinica Chimica Acta, 394(1-2), 42-46. PubMed

Helander, A., Husa, A., & Jeppsson, J.O., (2003) Improved HPLC method for carbohydrate-deficient transferrin in serum. Clinical Chemistry, 49(11), 1881-1890. PubMed

Jeppsson, J.O., Arndt, T., Schellenberg, F., Wielders, J.P., Anton, R.F., Whitfield, J.B., & Helander, A., (IFCC-WG-CDT), (2007) Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clinical Chemistry and Laboratory Medicine, 45(4), 558-562. PubMed

Helander, A., Kenan Moden N. (2013) Effect of Transferrin Glycation on the Use of Carbohydrate-Deficient Transferrin as an Alcohol Biomarker. Alcohol and Alcoholism, 1-5 PubMed

Addiction Specialists

Anton R. F., Lieber C., Tabakoff B., & CDTect Study Group, (2002).  Carbohydrate-deficient transferrin and gamma-Glutamyltransferase for the detection and monitoring of alcohol use: Results from a multisite study. Alcoholism: Clinical and Experimental Research, 26(8), 1215-1222. PubMed

Center for Substance Abuse Treatment, (2006).  The role of biomarkers in the treatment of alcohol use disorders. Substance Abuse Treatment Advisory, 5(4), 1-8. 

Cluver, J. S., Miller, P.M., & Anton, R. F., (2007). Case studies of the utility of serum carbohydrate-deficient transferrin (%CDT) in the clinical management of alcoholics. Journal of Addiction Medicine, 1(1), 44-47.

Fleming, M. F., Anton, R. F., & Spies, C. D., (2004).  A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.  Alcoholism: Clinical and Experimental Research, 28(9), 1347-1355. PubMed

Miller, P. M., Dominick, C. S., & Anton, R. F., (2004).  Carbohydrate-deficient transferrin test: A tool for detecting alcohol abuse. Current Psychiatry, 5(6), 80-87.

Surgery and Internal Medicine

Dillie, K. S., Mundt, M., French, M. T., & Fleming, M. F., (2005).  Cost-benefit analysis of a new alcohol biomarker, carbohydrate-deficient transferrin, in a chronic illness primary care sample.   Alcoholism: Clinical And Experimental Research, 29(11), 2008-2014. PubMed

Miller, P. M., & Anton, R. F., (2004).  Biochemical alcohol screening in primary healthcare.  Addictive Behaviors, 29(7), 1427-1437. PubMed

Miller, P. M., Spies, C., Neumann, T., Javos, M. A., Hoyumpa, A. M., Roache, J., Webb, A., Kashi, M., Sharkey, F. E., Anton, R. F., Egan, B. M., Basile, J., Nguyen, S., Fleming, M. F., Dillie, K. S., (2006).  Alcohol biomarker screening in medical and surgical settings. Alcoholism: Clinical and Experimental  Research, 30(2), 185-193. PubMed

Spies, C. D., Kissner, M., Neumann, T., Blum, S., Voigt, C., Funk, T., Runkel, N., & Pragst, F., (1998).  Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men. Alcohol & Alcoholism, 33(6), 661-669. PubMed

 

Contact the CNL

Clinical Neurobiology Laboratory
67 President Street, PH144
Charleston, SC 29425
843-792-5441
843-792-7371 (fax)
cnl@musc.edu